Document Classification

Section Type: METHODS

Text: Group I received L-758, 298 100 mg intravenously (i. v.), then dexamethasone 20 mg i. v., and cisplatin > or = 70 mg/m (2) on Day 1 followed by 300 mg MK-869 (tablet) orally on Days 2-5 ; Group II received L-758, 298 100 mg i. v., then dexamethasone 20 mg i. v., and cisplatin > or = 70 mg/m (2) on Day 1 followed by placebo on Days 2-5 ; and Group III received ondansetron 32 mg i. v., then dexamethasone 20 mg i. v., and cisplatin > or = 70 mg/m (2) on Day 1 followed by placebo on Days 2-5.